1. Home
  2. GMGI vs NMRA Comparison

GMGI vs NMRA Comparison

Compare GMGI & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMGI
  • NMRA
  • Stock Information
  • Founded
  • GMGI 2008
  • NMRA 2019
  • Country
  • GMGI United States
  • NMRA United States
  • Employees
  • GMGI N/A
  • NMRA N/A
  • Industry
  • GMGI Computer Software: Prepackaged Software
  • NMRA
  • Sector
  • GMGI Technology
  • NMRA
  • Exchange
  • GMGI Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • GMGI 255.9M
  • NMRA 287.6M
  • IPO Year
  • GMGI N/A
  • NMRA 2023
  • Fundamental
  • Price
  • GMGI $1.99
  • NMRA $0.91
  • Analyst Decision
  • GMGI Strong Buy
  • NMRA Buy
  • Analyst Count
  • GMGI 1
  • NMRA 8
  • Target Price
  • GMGI $4.00
  • NMRA $10.14
  • AVG Volume (30 Days)
  • GMGI 118.4K
  • NMRA 1.2M
  • Earning Date
  • GMGI 03-24-2025
  • NMRA 03-03-2025
  • Dividend Yield
  • GMGI N/A
  • NMRA N/A
  • EPS Growth
  • GMGI N/A
  • NMRA N/A
  • EPS
  • GMGI N/A
  • NMRA N/A
  • Revenue
  • GMGI $151,115,532.00
  • NMRA N/A
  • Revenue This Year
  • GMGI $36.68
  • NMRA N/A
  • Revenue Next Year
  • GMGI N/A
  • NMRA N/A
  • P/E Ratio
  • GMGI N/A
  • NMRA N/A
  • Revenue Growth
  • GMGI 62.50
  • NMRA N/A
  • 52 Week Low
  • GMGI $1.70
  • NMRA $0.90
  • 52 Week High
  • GMGI $6.27
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • GMGI 46.87
  • NMRA 23.28
  • Support Level
  • GMGI $2.00
  • NMRA $1.12
  • Resistance Level
  • GMGI $2.18
  • NMRA $1.13
  • Average True Range (ATR)
  • GMGI 0.10
  • NMRA 0.09
  • MACD
  • GMGI -0.01
  • NMRA 0.03
  • Stochastic Oscillator
  • GMGI 37.68
  • NMRA 2.47

About GMGI Golden Matrix Group Inc.

Golden Matrix Group Inc is an established gaming technology company that develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers, located in the Asia Pacific region. The company operates in two reportable segments; B2B and B2C. The B2C segment earns majority revenue. The company operates in UK, Asia Pacific and Latin America. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, R Kings Competitions and GM-AG.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: